Phase II Study to Evaluate the Efficacy of a Chemotherapy Combination With Imatinib (Glivec) and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct.

Trial Profile

Phase II Study to Evaluate the Efficacy of a Chemotherapy Combination With Imatinib (Glivec) and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2011

At a glance

  • Drugs Fluorouracil (Primary) ; Imatinib (Primary) ; Folinic acid
  • Indications Biliary cancer; Gallbladder cancer
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 07 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top